Heron Therapeuti
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $37,200 | $38,903 | $40,781 | $32,810 |
Gross Profit | 27,343 | 30,446 | 30,553 | 23,352 |
EBITDA | -1,637 | 3,705 | 8,734 | -3,877 |
EBIT | -2,248 | 3,154 | 8,153 | -4,458 |
Net Income | -2,381 | 2,635 | 3,663 | -4,848 |
Net Change In Cash | 37,200 | 38,903 | 40,781 | 32,810 |
Free Cash Flow | -11,076 | -8,979 | -12,418 | 2,940 |
Cash | 16,516 | 19,269 | 25,802 | 25,741 |
Basic Shares | 154,020 | 153,490 | 153,151 | 152,830 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $144,285 | $127,044 | $107,672 | $86,346 |
Gross Profit | 105,637 | 61,939 | 52,798 | 40,325 |
EBITDA | -5,056 | -103,792 | -171,769 | -214,807 |
EBIT | -7,548 | -106,691 | -174,658 | -217,828 |
Net Income | -13,580 | -110,559 | -134,516 | -217,662 |
Net Change In Cash | 144,285 | 127,044 | 107,672 | 86,346 |
Cost of Revenue | -14,597 | |||
Free Cash Flow | -24,235 | -60,334 | -148,737 | -206,376 |
Cash | 25,802 | 28,677 | 15,364 | 90,541 |
Basic Shares | 152,449 | 138,135 | 108,876 | 98,471 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.02 |
2025-03-31 | $0.01 |
2024-12-31 | $0.02 |
